Pinned Tweet
You can subscribe to our #free weekly newsletter of the top #pharmaceutical and #healthcare stories of the week. #newsletter #BigPharma #BiotechNews
purepharmanews.com/subscribe…
2021 US #FDA approvals filled with first-in-class drugs. Find out more here ➡️purepharmanews.com/us-fda-nm…
#Pharmaceuticals #pharmaindustry #regulatory
Cash injection for #Biogen as it sells its Samsung Bioepis stake for USD2.3bn #biosimilars #SamsungBioepis
purepharmanews.com/biogen-se…
Pure Pharma News retweeted
Bioelectronic medicine may sound like sci-fi, but the concept is simple, and closer than you think! Swipe to see how #bioelectronics is aiming to tackle a range of chronic diseases using a small device implanted through keyhole surgery 👉 w/ @GBioelectronics
Incyte to withdraw #parsaclisib NDA in blood cancers.
purepharmanews.com/incyte-wi…
#bloodcancer #NDA
Check out the #PDUFA target action dates lined up for February and the key products awaiting approval....
purepharmanews.com/february-…
#Pharmaceutical #FDA
Pure Pharma News retweeted
PROTAC targeted protein degraders: the past is prologue go.nature.com/3rwBUQb - a new review by @miklosbekes and David Langley @ArvinasInc and @CraigMCrews covering the status of clinical translation of targeted protein degradation and key areas for the future of the field
As #Vimpat heads towards patent expiry, UCB agrees to acquire #Zogenix, which will bolster UCB's #epilepsy portfolio.
purepharmanews.com/ucb-agree…
Daiichi Sankyo de-diversifying to focus on #oncology
purepharmanews.com/daiichi-s…
#Pfizer is strengthening its #mRNA pipeline through agreements. #deals #Pharmaceutical #Pharma #drugdevelopment
Find out with who➡️purepharmanews.com/pfizer-bo…
Sanofi taps #Exscientia for #AI driven drug development worth up to USD5.2bn to help fill #pipeline.
#Pharmaceutical #drugdevelopment
purepharmanews.com/sanofi-ex…
J&J aims to strengthen its multiple myeloma franchise with #teclistamab US FDA submission. #bloodcancer #cancer #Pharmaceuticals
purepharmanews.com/teclistam…
1
This week's top #pharmaceutical stories including news from #Pfizer, #CytoDyn and more #COVID #migraine - mailchi.mp/63c06c02ffcb/this…
This week's top pharmaceutical stories - mailchi.mp/f1deed6e72dc/this…
This week's top pharmaceutical stories - mailchi.mp/82e0c5f9d1d4/this…
Interested in upcoming #FDA #PDUFA goal dates for October? Find out more here: purepharmanews.com/october-2…
#Pharmaceuticals
This week's top pharmaceutical stories - mailchi.mp/a45c465c6a34/this…
This week's top pharmaceutical stories - mailchi.mp/540e676290bf/this…
This week's top pharmaceutical stories - mailchi.mp/794a4792a5ce/this…
This week's top pharmaceutical stories - mailchi.mp/7becb16a2a84/this…
Pure Pharma News retweeted
FDA approves the first interchangeable biosimilar insulin product in the U.S. for the treatment of diabetes. Approval of insulin products can provide patients with additional safe, high-quality & potentially cost-effective options for treating diabetes. go.usa.gov/xFBYc














